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The hypothesis that the unsaponifiable fraction of olive oil dramatically influences hepatic gene expression was tested in mice. Two olive oils,
obtained from the same olive cultivar but by different technological procedures, were characterized to show that they differed mainly in terms
of the composition/quantity of this unsaponifiable fraction. Using DNA microarrays, hepatic gene expression was analysed in apoE-deficient
mice fed one of two isoenergetic, isonitrogenous diets containing either 10% (w/w) olive oil or unsaponifiable fraction-enriched olive oil. To pro-
vide an initial screening of potential candidate genes involved in a differential response, only genes with remarkably modified expression (signal
log2 ratio .3 or ,23) were further considered. The eleven genes fulfilling these prerequisites were confirmed by quantitative RT–PCR, and then
analysed in apoE-deficient mice with a C57BL/6J genetic background. Orosomucoid and serum amyloid A2 were upregulated (to variable extents
depending on the genetic background) in the absence of hepatic steatosis and inflammation. Fabp5 andMt2 were also strongly upregulated. Several
proteases were highly suppressed by the unsaponifiable-enriched olive diet, independent of the genetic background. The findings indicate that
change in the expression of these genes is a good marker of the intake of the unsaponifiable fraction of olive oil. The results highlight the important
biological effects of the unsaponifiable fraction of olive oil. The term ‘monounsaturated fatty acid-enriched oil’ no longer appears appropriate for
describing all the oils to which it is currently applied since it does not adequately reflect that they have different biological effects.
Apolipoprotein E-deficient mice: Olive oil: Unsaponifiable fraction
The ‘Seven Countries’ study showed that the so-called Medi-
terranean diet is associated with a reduced risk of cardiovascu-
lar mortality despite its associated high intake of fat, mainly
derived from olive oil (Keys et al. 1986; Keys, 1995). It has
also been shown that MUFA-containing oils reduce total and
LDL cholesterol levels with no proportionate reduction of
HDL cholesterol levels (Mattson & Grundy, 1985; Mensink
& Katan, 1989; Mata et al. 1992). A whole panoply of exper-
imental work has been designed to explain these epidemiolo-
gical and clinical data. However, MUFA-enriched diets have
selective physiological effects in man, indicating that other
components, e.g. TAG species or non-fatty acids, rather than
the oleic acid content alone, might be responsible for the
benefits of virgin olive oil (Ruiz-Gutierrez et al. 1996; Kris-
Etherton et al. 1999; Abia et al. 2001; Perona et al. 2003,
2006). Similar findings have also been described in animal
studies dealing with the effects of olive oil on the vascular
wall (Calleja et al. 1999; Herrera et al. 2001). When studying
the biological effects of olive oil it should be remembered that
it is more than a simple mixture of fatty acids, and that it con-
tains other biologically active substances such as tocopherols,
polyphenols and phytosterols, some of which have antioxidant
and anti-inflammatory activities (Visioli et al. 2000, 2003; de
la Puerta et al. 2001; de la Puerta-Vazquez et al. 2004; Perona
et al. 2006).
In Spain, unsaponifiable fraction-enriched olive oil is
known as orujo or olive-pomace oil, and is extracted by the
secondary centrifugation of the residue left after obtaining
virgin olive oil. Improved procedures for the extraction of
this oil now allow it to be obtained with higher concentrations
of terpenoids, tocopherols, phytosterols and waxes from the
epicarp of the olive – compounds that are in low concen-
tration in virgin olive oil (Pe´rez-Camino & Cert, 1999). The
nutritional value of this innovative olive oil preparation has
not yet been studied, although the biological activity of most
of these compounds is now being unveiled. We recently
reported the vasorelaxant effects of oleanolic acid and
erythrodiol, two triterpenoids found in orujo, on rat aorta
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(Rodriguez-Rodriguez et al. 2004), as well as the improve-
ment obtained with the unsaponifiable fraction of virgin
olive oil in the balance between the vasoprotective and pro-
thrombotic factors released by endothelial cells (Sanchez
Perona et al. 2004).
The liver produces a number of lipoproteins (VLDL and
HDL), apo and enzymes. The latter (hepatic lipase, lecithin
cholesterol acyltransferase and phospholipid transfer protein)
are involved in the plasma transformation of lipoproteins
(den Boer et al. 2004). ApoE-deficient mice develop spon-
taneous atherosclerosis (Osada et al. 2000) and cognitive def-
icits resembling those of Alzheimer’s disease and ageing, and
therefore provide a model for all these problems (Masliah et al.
1995; Oitzl et al. 1997; Krzywkowski et al. 1999). When fed
high-fat diets these mice show slight hepatic steatosis that
responds to dietary manipulations such as changing the type
of linoleic acid isomer provided (Arbone´s-Mainar et al.
2006a). These steatotic variations have been associated with
the development of atherosclerotic lesions (Arbone´s-Mainar
et al. 2006b). Thus, the liver may undergo important meta-
bolic changes under the influence of olive oil, mediated
through changes in plasma lipoprotein concentration, and the
steatotic-prone liver of apoE-deficient mice offers an excellent
model in which to verify this. To test the hypothesis that the
unsaponifiable fraction of olive oil significantly influences
hepatic gene expression, apoE-deficient mice of different gen-
etic backgrounds were fed diets supplemented with either
10% (w/w) olive oil or 10% unsaponifiable fraction-enriched
olive oil. Gene expression was then determined by microarray
analysis and confirmed by real-time RT–PCR.
Methods and material
Animals
The experimental animals were seventeen two-month-old male,
homozygous apoE KO mice with a C57BL6J £ OLA129 gen-
etic background, and twelve homozygous apoE KO mice
with a C57BL6J genetic background, all bred at the Unidad
Mixta de Investigacio´n, University of Zaragoza. To confirm
that the initial plasma cholesterol and TAG concentrations
of these animals were the same, blood samples were taken
(after overnight fasting) from the retroorbital plexus after
isofluorane anaesthetization. All mice were housed in
sterile filter-top cages in rooms maintained under a 12 h light–
12 h dark cycle. All had access ad libitum to food and
water. The study protocol was approved by the Ethics Commit-
tee for Animal Research of the University of Zaragoza. Body
weights and food intake were recorded throughout the
experiment.
Diets
Two study groups were established: (1) one received a chow
diet (Teklad Mouse/Rat Diet no. 2014; Harlan Teklad,
Harlan Ibe´rica, Barcelona, Spain) supplemented with 10%
(w/w) olive oil obtained by a conventional procedure (OO
diet) (n 9 and n 6 for the first and second experiments respect-
ively; see later), and (2) the other received the same chow
diet but supplemented with 10% (w/w) unsaponifiable frac-
tion-enriched olive oil (UEOO diet; n 8 and n 6 for the
first and second experiments respectively; see later). This
unsaponifiable fraction-enriched olive oil was manufactured
by an innovative procedure (Pe´rez-Camino & Cert, 1999).
Both olive oils were obtained from the same cultivar, con-
tained the same TAG species and both were refined to elimin-
ate the influence of soluble phenol compounds. All diets were
prepared weekly and stored in an N2 atmosphere at 2208C.
Fresh food was provided daily. The animals were fed the
experimental diets for 11 weeks; both were well tolerated.
The unsaponifiable fraction was characterized as previously
described (de la Puerta-Vazquez et al. 2004).
Plasma analyses
At the end of the experimental period and after an overnight
fast, the animals were killed by suffocation with CO2 and
blood was drawn from their hearts. Plasma serum amyloid
A concentrations were evaluated by immunoassay using a
rat monoclonal anti-mouse serum amyloid A antibody (Bio-
Source International, Camarillo, CA, USA) as the primary
antibody (intra-day CV of this assay was 15% for positive
control). Plasma a1-acid glycoprotein (orosomucoid) concen-
trations were determined by the single radial immunodiffusion
test using the mouse a1-AG plate kit (Cardiotech Services,
Louisville, KY, USA) and were processed the same day
(intra-day CV of this assay was 4% for positive control).
Analysis of hepatic lipids
To determine hepatic cholesterol and TAG concentrations,
lipids were extracted from 100mg tissue using the method
of Folch et al. (1957), employing 2,6-di-tert-butyl-p-cresol
as an antioxidant. The extracted lipids were redissolved in
1ml of chloroform–methanol (2 : 1, v/v) and stored at
2208C until analysis. The lipid classes were determined by
HPLC as described by Perona & Ruiz-Gutierrez (2004). Stan-
dard solutions of cholesteryl oleate, triolein, cholesterol and
phosphatidylcholine, prepared in chloroform–methanol (2 : 1,
v/v), were used for the identification and quantification of
cholesteryl esters, TAG, free cholesterol and phospholipids,
respectively.
RNA isolation, Affymetrix oligonucleotide array hybridization
and data analysis
Immediately after the animals were killed the livers were
removed and frozen in liquid nitrogen. RNA from each
liver was isolated using Trigent reagent (MRC, Cincinatti,
OH, USA). DNA contaminants were removed by TURBO
DNAse treatment using the DNA removal kit from
AMBION (Austin, TX, USA). RNA was quantified by absor-
bance at A260/280 (the A260/280 ratio was greater than 1·75). The
integrity of the 28S and 18S ribosomal RNA was verified
by agarose formaldehyde gel electrophoresis followed by
ethidium bromide staining. Images were captured and ana-
lysed using a Bio-Rad image analysis system and Molecular
Analyst (Bio-Rad, Madrid, Spain). The 28S/18S ratio was
greater than 2.
Aliquots (20mg) of total liver RNA from each mouse of
each group (n 9 for the OO group and n 8 for the UEOO
group) were pooled to avoid problems of individual variation,
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and purified using the RNeasy system (Quiagen, Barcelona,
Spain). Total liver RNA (8mg) was then used for biotin label-
ling. Hybridization, washing, scanning and analysis with the
Affymetrix GeneChip Murine Genome MOE430A array
(Affymetrix, Santa Clara, CA, USA) were performed accord-
ing to the standard Affymetrix protocols used at Progenika
Biopharma (Derio, Spain). Fluorometric data were generated
by Affymetrix software, and the fluorimetric signal adjusted
so that all the probe sets provided intensities within a manage-
able range. Transcripts with signal intensities that were lower
than the noise of the matrix (^3 SD) were not taken into
account. The data obtained in the microarray hybridizations
were processed with Microarray Suite 5.0 (Affymetrix) soft-
ware. The identification of genes that were up- or down-regu-
lated by the unsaponifiable fraction was performed by
comparing gene expressions in the livers of animals from
the two diet groups (significance set at P,0·01). Of these
we selected only those whose signal log2 ratio was higher
than 1·5 (up-regulated genes) or lower than 21·5 (down-regu-
lated genes). Signal log2 ratio is now recommended by Affy-
metrix software and several authors (Gilsbach et al. 2006)
because of the linear response observed in contrast to fold
change. The complete datasets were deposited in the Gene
Expression Omnibus (GEO) database (accession number
GSE2261).
Quantification of mRNA
The differences in mRNA expression observed with the micro-
arrays was confirmed by Northern blotting and quantitative
real-time RT–PCR (qRT–PCR) analysis of individual
samples. Northern blot analysis was performed as previously
described (Acı´n et al. 2005). The mouse clones for apoa5
(4196296 IMAGE Clone) and pon1 (4158951 IMAGE
Clone) were obtained from MGC Geneservice (Cambridge,
UK). The probes used were those previously described:
apoa5 (Arbone´s-Mainar et al. 2006a) and pon1 (Acı´n et al.
2005). A mouse b-actin fragment (Acı´n et al. 2005) was
used to normalize the amount of RNA. Labelling and quanti-
fication were performed as previously described (Acı´n et al.
2005).
Equal amounts of DNA-free RNA from each sample of
each animal were used in qRT–PCR analyses. First-strand
cDNA synthesis and the PCR reactions were performed
using the SuperScript III Platinum Two-Step qRT–PCR Kit
with SYBR Green (Invitrogen, Madrid, Spain), according to
the manufacturer’s instructions and as previously described
(Arbone´s-Mainar et al. 2006a). The primers used were
designed by Primer Expressw (Applied Biosystems, Foster
City, CA, USA): for chymotrypsinogen – sense, 50-CAG
CAC CAT GGC ATT CCT TT-30, antisense, 50-GCA TCC
TCT CCG TTG ACG AT-30; for elastase 2 – sense, 50-ACT
GAA TTG CCG GGC ATC TA-30, antisense, 50-GTT CCT
TGC CAT CAC CGA GT-30; for fatty acid binding protein
5 – sense, 50-GAC GGT CTG CAC CTT CCA AG-30, anti-
sense 50-CAG GAT GAC GAG GAA GCC C-30; for glucoki-
nase – sense, 50-ACG ACC CCT GCT TAT CCT CA-30,
antisense, 50-CAC GGT CCA TCT CCT TCT GC-30; for
leptin receptor – sense, 50-TGA CTT GCA GAT GGT CAC
CC-30, antisense, 50-AAG CCG TCT CTC TGT AAG ACG
C-30; for metallothionein 2 – sense, 50-TCG GAA TCT
TCA CTC TTC AAA CC-30, antisense, 50-CCA TCG GAG
GCA CAG GAG-30; for nicotinamide N-methyltransferase –
sense, 50-CCT GGG CAG TCT GCT CAA G-3, antisense,
50-AAT GGT GTA ACC GGC CTC TTC-3; for orosomucoid
2 – sense, 50-TTG GAA GCT CAG AAC CCA GAA-30, anti-
sense, 50-TCG AAG CTC CAT CGT GTC ATT-30; for pan-
creatic lipase 2 – sense, 50-GGA GCC CAG CAC AGA
TCA AC-30, antisense, 50-GCC AGT TTT CTT CTC CCT
TGT C-30; for serum amyloid A 2 – sense, 50-CTG GCT
GGA AAG ATG GAG AC-30, antisense, 50-TGT CCT CGT
GTC CTC TGC-30; for trypsin 4 – sense, 50-CTT CAA
TGC CTG GAT GCC C-30, antisense, 50-CAG GAG ACA
ATG CCC TGG AG-30; and for b-actin – sense, 50-CTG
ACT GAC TAC CTC ATG AAG ATC CT-30, antisense, 50-
CTT AAT GTC ACG CAC GAT TTC C-30. The specificity
of the PCR reaction was confirmed by sequencing the products
after their electrophoretic separation in agarose gels. Real-time
RT–PCR reactions were performed in an ABI PRISM 7700
Sequence Detector (Applied Biosystems) following the stan-
dard procedure. The relative amount of all mRNA was calcu-
lated using the comparative 22DDCt method. b-actin mRNA
was used as the invariant control.
Liver histology analysis
Aliquots of liver were stored in neutral formaldehyde and
embedded in paraffin. Sections (4mm) were stained with
haematoxylin and eosin and observed with a Nikon micro-
scope.
Statistical analysis
The Mann–Whitney U test, according to the Algoritm of
Microarray Suite 5.0 (Affymetrix), was used to compare the
mean fluorimetric signal intensities of eleven to twenty perfect
match probe per probe set hybridized to liver RNA from the
OO group with those obtained for the UEOO group and in
either case subtracted the intensities of a similar number of
mismatched probes (background hybridization). Significance
was set at P,0·01. Correlations between variables were
tested by calculating the Spearman’s rank-order correlation
coefficient (rs); tests were performed using Instat 3.02 soft-
ware for Windows (GraphPad, San Diego, CA, USA).
Results
Dietary characteristics
Tables 1 and 2 show the lipid composition of the two olive
oils used. Their composition in linolenic fatty acid, SFA and
MUFA was similar (Table 1), but the composition of the
unsaponifiable fraction was different (except for squalene)
(Table 2): the unsaponifiable fraction-enriched olive oil had
greater quantities of phytosterols, waxes, triterpenes (erythro-
diol, uvaol and maslinic) and tocopherols.
No significant difference in weight gain (4·4 (SD 0·2) for the
OO group compared to 4 (SD 0·3) g for the UEOO group)
or food intake (3·9 (SD 0·3) for the OO group compared to
3·8 (SD 0·2) g for the UEOO group) was observed between
the animals of the two diet groups. Similarly, the weight of
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the liver appeared unaltered by the administration of either
diet (0·79 (SD 0·05) and 0·76 (SD 0·02) g, respectively).
Gene expression in livers of apoE-deficient mice fed the
different diets
To determine the changes in hepatic gene expression induced by
the unsaponifiable fraction of olive oil, the expression of 22 690
transcripts represented on the Affymetrix GeneChip Murine
GenomeMOE430Aarraywas quantified in pooled liver samples
of nine animals that received the OO diet and another eight that
received the UEOO diet. The livers of OO animals expressed
10 455 transcripts, while those of the UEOO animals expressed
10 675 (identified as ‘present’ by Affymetrix software). Using
the Mann–Whitney ranking feature of the Affymetrix software
to determine significant differences in gene expression
(P,0·01), the increased expression of 920 sequences plus the
reduced expression of 420 sequences was identified in samples
from the animals on the UEOO diet compared to those on the
OO diet when no multiple test correction was applied. When
the latter was taken into consideration by removing expressions
with similar gene symbols, identical accession number and iden-
ticalUNIGENEnumber, the number of geneswith increased and
repressed expression was reduced to 660 and 324, respectively.
To select the most relevant, only differentially regulated genes
with a signal log2 ratio higher than 1·5 (for those genes up-regu-
lated) or lower than 21·5 (for those repressed) were taken into
account. Tables 3 and 4 list the genes whose mRNA reflected
these expressions. Thirty genes fulfilled the criterion of showing
increased expression as a response to the unsaponifiable fraction
of olive oil (Table 3). Five of these genes coded for acute phase
proteins (Orm1, Orm2, Orm3, Saa1 and Saa2), four coded for
proteins belonging to the extracellular space (Apcs, Fgl1, Prg4
and Sdc4), three were involved in signal transduction (Egfr,
Lepr and Sesn1), three in electron transport (Cyp17a1,
Cyp2b20 and Qscn6) and two in protein metabolism (Ren1
and Serpina3n). A further three were enzymes involved in
acetyl-CoA (Pdk4), fatty acid (Scd1) and bile acid (Cyp7a1) bio-
synthesis, two coded for ion binding proteins (Mt1 andMt2), two
formetabolite transport proteins (Fabp5 and Lcn2), four for pro-
teins with miscellaneous functions (e.g. one was involved in
apoptosis (Bcl2 l), another was an enzyme involved in nicotina-
mide metabolism (Nnmt), one was a member of the complement
cascade (Cfh) and one was a transcription factor (Gadd45 g).
Finally, two genes coded for unknown expressed sequence
tags. Twenty-four genes met the criterion of showing a reduced
expression as a response to the presence of the unsaponifiable
fraction of olive oil (Table 4). Of these, eight were involved in
proteolysis (Cpa1, Cpb1, Chym, Ela1, Ela2, Ela3b, Prss2 and
Try4), four in lipid metabolism (Clps, Cel, Pnlip and Pnliprp1),
three in glutathione conjugation (Gsta2, Gsta4 and Gstm3), two
coded for heat shock proteins (Hspa1a andHspb1), two for tran-
scription factors (Nr1d1 and Dbp), one for an enzyme involved
in carbohydrate metabolism (Gck), three for proteins with mis-
cellaneous functions (one extracellular receptor (Dmbt1), one
enzyme involved in RNAmetabolism (Rnase1) and one cell sur-
face protein (Sycn)), and finally one for an unknown expressed
sequence tag.
To validate the results obtained with the microarray, the
expressions of eleven genes – Chym, Ela2, Fabp5, Gck,
Lepr, Mt2, Nnmt, Orm2, Pnlip, Saa2, Try4 – that were strik-
ingly up- or down-regulated (signal log2 ratio .3 or ,23)
were individually studied by specific qRT–PCR assays.
b-actin was used to normalize the results that are shown in
Table 5. The six up-regulated genes included in the validation
analysis – Fabp5, Lepr, Mt2, Nnmt, Orm2, Saa2 – appeared
Table 2. Composition of the unsaponifiable fraction of the olive oils used
(mg/kg, w/w)
Component Olive oil Unsaponifiable fraction-enriched olive oil
Erythrodiol þ uvaol 17 500
Maslinic acid 0 110
Squalene 2600 2500
Total phytosterols 1120 2240
Total tocopherols 220 981
Waxes 120 3400
Table 1. Fatty acid composition of the olive oils used (g/100 g, w/w)
Fatty acids Olive oil Unsaponifiable fraction-enriched olive oil
Myristic (14 : 0) 0·02 0·02
Palmitic (16 : 0) 10·98 10·29
Stearic (18 : 0) 3·53 2·95
Arachidic (20 : 0) 0·42 0·45
Behenic (22 : 0) 0·12 0·17
Lignoceric (24 : 0) 0·05 0·07
Palmitoleic (16 : 1) 0·82 0·76
Oleic (18 : 1) 77·80 74·27
Gadoleic (20 : 1) 0·25 0·33
Linoleic (18 : 2n-6) 4·52 8·07
Linolenic (18 : 3n-3) 0·62 0·70
SFA 15·14 13·95
MUFA 78·87 75·36
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Table 3. Hepatic genes up-regulated by the unsaponifiable fraction of olive oil*
Biological process GenBank Affymetrix ID Name Gene symbol Olive oil UE olive oil Signal log2 ratio
Acetyl-CoA biosynthesis NM_013743 1417273_at Pyruvate dehydrogenase kinase 4 Pdk4 20·6 96·1 1·9
Acute phase response BE628912 1451054_at Orosomucoid 1 Orm1 702 3087·5 2
Acute phase response NM_011016 1420438_at Orosomucoid 2 Orm2 71·5 1496·9 3·9
Acute phase response NM_013623 1450611_at Orosomucoid 3 Orm3 20·7 115·1 2·3
Acute phase response NM_009117 1450788_at Serum amyloid A 1 Saa1 2017·4 5175·9 1·5
Acute phase response NM_011314 1449326_x_at Serum amyloid A 2 Saa2 858·1 4291·9 3·3
Apoptosis NM_009743 1420887_a_at Bcl-xl Bcl2 l 20·1 103 2·9
Bile acid metabolism NM_007824 1422100_at Cytochrome P450, 7a1 Cyp7a1 109·9 495·4 2·5
Metal binding protein BC027262 1451612_at Metallothionein 1 Mt1 15·1 88·1 2·9
Metal binding protein AA796766 1428942_at Metallothionein 2 Mt2 420·7 4657 3·1
Complement cascade AI987976 1450876_at Complement component factor h Cfh 70·4 234·3 1·8
Electron transport NM_007809 1417017_at Cytochrome P450, 17a1 Cyp17a1 34·2 146·1 1·9
Electron transport AF128849 1451787_at Cytochrome P450, 2b20 Cyp2b20 185·3 615·6 1·8
Electron transport AK004880 1420832_at Quiescin Q6 Qscn6 313·2 688·9 1·5
Extracellular space NM_011318 1419059_at Serum amyloid P Apcs 902·2 4829·2 2·2
Extracellular space BC005679 1417654_at Syndecan 4 Sdc4 275·6 1978·7 2·9
Extracellular space NM_021400 1449824_at Proteoglycan 4 Prg4 83·8 373·2 2·1
Extracellular space BC021946 1424599_at Fibrinogen-like protein 1 Fgl1 1698·1 4164 1·6
Fatty acid synthesis NM_009127 1415965_at Stearoyl-coenzyme A desaturase Scd1 195·3 721·1 1·8
Methyl transferase AK006371 1432517_a_at Nicotinamide N-methyltransferase Nnmt 107·1 1158·3 3·4
Protease inhibitor NM_009252 1419100_at Proteinase inhibitor, A3N Serpina3n 935·4 2959·6 1·5
Proteolysis NM_031192 1448975_s_at Renin 1 Ren1 48·6 269·9 2·7
Signal transduction U42467 1425644_at Leptin receptor Lepr 2·8 166·1 5·8
Signal transduction U03425 1424932_at Epidermal growth factor receptor Egfr 148·6 446·8 1·5
Signal transduction BG076140 1433711_s_at Sestrin 1 Sesn1 63·4 166·9 1·5
Transcription factor AK007410 1453851_a_at Growth arrest and DNA-damage-inducible 45 Gadd45 g 96·5 240·3 1·5
Transport (fatty acids) BC002008 1416022_at Fatty acid binding protein 5 Fabp5 32·6 238·5 3
Transport (fatty acids) X14607 1427747_a_at Lipocalin 2 Lcn2 400·9 3304·6 2·9
AK017926 1428306_at Expressed sequence tag – 80·9 359·2 2·4
AV291259 1429144_at Expressed sequence tag – 341·9 1280·7 1·7
UE, unsaponifiable fraction-enriched.
*Data represent intensity of signal for each condition with the Affymetrix chip. For details of procedures, see p. 630.
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Table 4. Hepatic genes down-regulated by the unsaponifiable fraction of olive oil*
Biological process GenBank Affymetrix ID Name Gene symbol Olive oil UE olive oil Signal log2 ratio
Carbohydrate metabolism BC011139 1419146_a_at Glucokinase Gck 63·8 7·9 23·2
Extracellular receptor NM_007769 1418287_a_at Endoglin Dmbt1 319·6 52·1 22·2
Glutathione conjugation NM_008182 1421040_a_at Glutathione S-transferase, a2 Gsta2 269 59·2 22·3
Glutathione conjugation NM_010357 1416368_at Glutathione S-transferase, a 4 Gsta4 219 47·1 22·1
Glutathione conjugation J03953 1427473_at Glutathione S-transferase, mu 3 Gstm3 217·2 45·3 21·9
Heat shock protein M12573 1427126_at Heat shock protein 1A Hspa1a 634 220·9 21·5
Heat shock protein U03561 1425964_x_at Heat shock protein 1 Hspb1 458·1 71·3 22·4
Lipid metabolism NM_025469 1415805_at Colipase, pancreatic Clps 393·1 51·3 22·8
Lipid metabolism BC006872 1417257_at Carboxyl ester lipase Cel 282·7 52 22·5
Lipid metabolism AI326372 1433431_at Pancreatic lipase Pnlip 858·3 78·6 23·3
Lipid metabolism NM_018874 1415777_at Pancreatic lipase related 1 Pnliprp1 246·5 16·6 22·7
Nuclease activity NM_011271 1416523_at Pancreatic ribonuclease A1 Rnase1 305·3 73·4 21·6
Proteolysis AK003088 1428062_at Carboxypeptidase A1 Cpa1 800·3 70·6 23·3
Proteolysis AK003061 1428102_at Carboxypeptidase B1 Cpb1 536·6 84·1 22·6
Proteolysis NM_025583 1448220_at Chymotrypsinogen Chym 778 59·2 23·3
Proteolysis BC011218 1423693_at Pancreatic elastase 1 Ela1 690·8 231 21·9
Proteolysis NM_007919 1448281_a_at Elastase 2 Ela2 666 79·6 23·3
Proteolysis NM_026419 1415884_at Pancreatic elastase 3B Ela3b 470·5 77·6 22
Proteolysis BI348548 1433459_x_at Trypsin 2 Prss2 549·3 86·1 22·6
Proteolysis AB009661 1415954_at Trypsin 4 Try4 436·3 29·4 24·1
Surface protein BC019567 1451228_a_at Syncollin Sycn 242·7 14·5 23
Transcription factor W13191 1426464_at Nuclear receptor 1 D 1 Nr1d1 262·3 59·8 21·8
Transcription factor BB550183 1438211_s_at Albumin promoter binding protein Dbp 116·5 46·1 21·5
BF581690 1428359_s_at Expressed sequence tag – 203·8 19·5 22·5
UE, unsaponifiable fraction-enriched.
*Data represent intensity of signal for each condition with the Affymetrix chip. For details of procedures, see p. 630.
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significantly increased in their expressions by the presence of
the unsaponifiable fraction of olive oil. The five down-regu-
lated genes selected – Chym, Ela2, Gck, Pnlip, Try4 – were
significantly decreased in mice receiving the diet enriched in
the unsaponifiable fraction of olive oil. Fig. 1 shows the cor-
relation between the mean values of signal log2 ratio for the
eleven genes with the microarray assay performed with
pooled samples (Tables 3 and 4), and the mean of each
group obtained after the analysis of samples from each
animal in both experimental groups (Table 5). Good agree-
ment between these procedures was obtained (r 0·9382,
P,0·0001) and all samples were correctly classified, although
in two cases the magnitude of the response differed
between both methods. Two genes showing mild expression
change (signal log2 ratio ,1·5), apolipoprotein 5 and paraox-
onase 1, were also studied by Northern blotting, which
confirmed their microassay results (data not shown). This indi-
cates that pooled samples can be successfully used to provide
an initial screening of gene expression in studies of this type,
with the attending economic and time savings although with
the limitation of no information on biological variability.
Plasma presence of unsaponifiable-activated gene products
Since five of the overexpressed genes (Orm1, Orm2, Orm3,
Saa1 and Saa2) coded for circulating proteins that may influ-
ence general homeostasis, their plasma levels were deter-
mined. If the remarkable changes observed in the hepatic
expression of these proteins were reflected in plasma to the
same degree, this would make them highly attractive markers
of the consumption of the unsaponifiable fraction of olive oil.
Serum amyloid proteins are well-known modifiers of plasma
lipoproteins but no physiological role for orosomucoid has
been proposed besides its role in the acute phase response
(Hochepied et al. 2003). Fig. 2(a) shows the results of Wes-
tern analysis of serum amyloid protein concentration. The
observed increase of Saa mRNA expression (Table 3) was
not reflected in plasma in either the OO or UEOO mice,
suggesting the absence of an acute phase reaction. To confirm
this lack of acute phase response, the livers of animals con-
suming the different diets were examined histologically.
Fig. 2(b) shows representative images of livers from animals
of the two diet groups. For comparison, an image of an
ApoE-deficient mouse of the same age that was fed the
chow diet with no added oil of any type is included (marked
as control group). The liver of this control animal shows
marked steatosis, in agreement with the described accumu-
lation of lipids in this model (Sehayek et al. 2000). Interest-
ingly, both experimental diets alleviated these steatotic
features. No inflammatory cells were detected in the liver of
any animal, suggesting that the UEOO diet does not induce
an acute phase response. However, the increased hepatic
Orm2 mRNA levels observed in the chip analysis were con-
firmed by qRT–PCR (Fig. 3(A)) and were reflected in the
plasma concentration of animals consuming the UEOO diet
(Fig. 3(C)). The present results indicate that the increase in
hepatic Orm2 mRNA leads to increased concentrations of
the protein product in plasma.
To determine whether this induction of Orm2 also occurred
in apoE-deficient mice with the C57BL/6J genetic back-
ground, their livers were studied for the expression of this
gene. Although the UEOO diets led to a reduction in hepatic
Table 5. Hepatic genes regulated by the unsaponifiable fraction of olive oil*
Olive oil (n 9) UE olive oil (n 8)
Mean SD Mean SD Fold change Signal log2 ratio
Genes up-regulated
Fabp5 1·0a 0·8 5·5b 0·4 5·3 2·4
Lepr 0·4a 0·5 4·1b 0·2 10·9 3·4
Mt2 0·5a 0·6 13·6b 1·5 29·1 4·8
Nnmt 0·1a 0·3 2·4b 0·4 16·8 4·1
Orm2 2·4a 0·3 75·2b 2 31·8 5·0
Saa2 3·4a 0·3 108·5b 1 32·2 5·0
Genes down-regulated
Chym 35·1a 0·1 5·7b 0·3 0·16 22·6
Ela2 16·2a 0·1 4·2b 0·3 0·26 21·9
Gck 3·7a 0·8 0·8b 0·6 0·21 22·2
Pnlip 12·2a 3 2·0b 0·2 0·16 22·6
Try4 15·2a 0·1 4·6b 0·6 0·30 21·7
UE, unsaponifiable fraction-enriched.
a,bMean values within a row with unlike superscript letters were significantly different (Mann–Whitney U test; P,0·001).
* Data represent arbitrary units normalized to the b-actin expression for each condition with the quantitative real-time RT–PCR. For
details of procedures, see p. 630.
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Fig. 1. Correlation analysis between microarray and quantitative real-time
RT–PCR (qRT–PCR) data. The expression of eleven genes – Chym, Ela2,
Fabp5, Gck, Lepr, Mt2, Nnmt, Orm2, Pnlip, Saa2 and Try4 – was individually
studied by qRT–PCR and normalized to the invariant b-actin gene. For
details of procedures, see p. 630. The mean values obtained for signal log2
ratio (SLR) from individual analyses (see Table 5) were plotted against the
microarray values which used pooled samples (see Tables 3 and 4). Good
agreement between the procedures was seen (r 0·9382, P,0·0001).
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Orm2 mRNA levels (Fig. 3(B)), surprisingly this was not
reflected at the plasma level (data not shown). The increase
in hepatic Orm2 mRNA expression is probably a specific
response elicited by the unsaponifiable fraction of olive oil,
and is not related to an acute phase response but conditioned
by the genetic background of the mice.
Effects of mouse genetic background on the response to
unsaponifiable fraction-enriched olive oil
To investigate which of the selected genes – Chym, Ela2,
Fabp5, Gck, Lepr, Mt2, Nnmt, Pnlip, Saa2, Try4 – were influ-
enced by the genetic background, their expressions in apoE-
deficient mice (C57BL/6J genetic background) receiving
both diets were assayed by qRT–PCR (normalized to the
invariant gene b-actin). The results are expressed as signal
log2 ratios in both genetic backgrounds (Fig. 4). Interestingly,
no Pnlip expression was detected in the livers of mice with the
C57BL/6J background and lesser variability of response was
observed in these mice. For the genes Lepr and Saa2, a signifi-
cant opposite response was seen in mice of different genetic
background. In contrast, for seven other genes the influence
of the UEOO diet was similar in both types of mice (Mt2,
Chym and Ela2 expressions), although the magnitude of
response significantly differed (more pronounced for the
Fabp5 gene in the C57BL/6J background, and less so in
genes Gck, Nnmt and Try4 in the C57BL/6J £ Ola129 back-
ground). The present results further illustrate that genetic
background may influence the response to the unsaponifiable
fraction of olive oil.
Discussion
The unsaponifiable fraction of olive oil remarkably influenced
the activity of several genes. The nutrigenomic approach of
the present work clearly shows the important effect of this
fraction. Some of its components, such as phytosterols
(Plosch et al. 2004) and vitamin E (Barella et al. 2004),
have been shown to affect the expression of certain genes.
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Fig. 3. Influence of genetic background on orosomucoid expression in apoE-
deficient mice consuming the different diets (OO diet, diet supplemented with
olive oil; UEOO diet, diet supplemented with unsaponifiable fraction-enriched
olive oil). (A), Plasma orosomucoid 2 levels in apoE-deficient mice with
C57BL/6J £ Ola129 genetic background. (B, C), mRNA expression for oroso-
mucoid 2 in livers of apoE-deficient mice with C57BL/6J £ Ola129 (B) and
C57BL/6J (C) genetic backgrounds (determined by quantitative real-time
RT–PCR). For details of procedures, see p. 630. Values are means with
their standard errors depicted by vertical bars. Mean values were significantly
different from those of the OO diet (Mann–Whitney U test): *P,0·001.
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Fig. 4. Influence of genetic background of apoE-deficient mice on the pattern
of gene expression in response to the diet supplemented with unsaponifiable
fraction-enriched olive oil (UEOO diet). Data are expressed as signal log2
ratios of hepatic mRNA expression (as determined by quantitative real-time
RT–PCR) for each gene in apoE-deficient mice with C57BL/6J £ Ola129 (A)
and C57BL/6J (B) genetic backgrounds consuming either the diet sup-
plemented with olive oil (OO diet) or the UEOO diet. Animals receiving the
OO diet were used as the reference against which to compare the effects of
the UEOO diet. For details of procedures, see p. 630. Values are means with
their standard deviations depicted by vertical bars. *P,0·001 between gen-
etic backgrounds according to the Mann–Whitney U test.
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Fig. 2. Absence of acute phase reaction in mice fed the different diets (OO
diet, diet supplemented with olive oil; UEOO diet, diet supplemented with
unsaponifiable fraction-enriched olive oil). (a), Plasma serum amyloid A
(SAA) Western blot analysis. Lane 1, a positive control corresponding to rat
plasma from an animal treated with turpentine to induce the acute phase
reaction. Lanes 2–4, plasma from mice consuming the different diets: chow,
OO diet and UEOO diet, respectively. Light chain Ig detection was used as a
loading control. (b), Representative liver micrographs from apoE-deficient
mice consuming the different diets (bars ¼ 25mm). For details of procedures,
see p. 630.
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Others, such as maslinic acid (Montilla et al. 2003; Ma´rquez-
Martı´n et al. 2006) and erythrodiol (Rodriguez-Rodriguez et al.
2004), are biologically active compounds but it is not known
whether they influence the expression of any gene. Indepen-
dent of the mechanism involved, the present results reveal
the additional effects of the unsaponifiable fraction with
respect to the influence of olive oil, and support the idea
that not all MUFA-containing oils behave in the same way
(Kritchevsky et al. 1984; Kris-Etherton et al. 1999).
The huge amounts of information provided by microarrays
requires further action be undertaken if meaningful and man-
ageable data are to be obtained, such as selecting only the
genes with the highest expression changes (Dutta et al.
2003; Vergnes et al. 2003; Artieda et al. 2005; Calpe-Berdiel
et al. 2005) or those involved in a certain metabolic pathway
(Horton et al. 2003; Kreeft et al. 2005). In the present work,
analysis was performed by subjecting the microarray data to
two rounds of selection. First, a restrictive step was performed,
selecting only those genes with a signal log2 ratio of ^1·5.
With this criterion, only thirty genes were found to be remark-
ably up-regulated and twenty-four notably down-regulated.
Second, only those genes whose expression was strongly
modified were deemed to be potential markers of the intake
of the unsaponifiable fraction. The strong modification of
the expression of these genes was individually confirmed by
qRT–PCR. Good agreement was observed between the Affy-
metrix chip and qRT–PCR data (Fig. 1). In high-density
microarrays, such as the Affymetrix MOE430A gene chip,
several probes are used for the same gene, therefore the
main concern regarding repeatability is the natural individual
variability of mRNA expression. Minimum information
about a Microarray experiment (MIAME) standards rec-
ommend using several chips for this reason (http://www.
mged.org/index.html), but this is not the only option and
sometimes it may be too stringent in terms of sample
demands, time, cost and the manageability of information.
The present data clearly show that pooling RNA from differ-
ent animals and using this in microarray analysis is a reliable
screening method for the search of biological effects in terms
of saving samples, time and economic resources, as other
authors have found (Napoli et al. 2002; Dutta et al. 2003;
Artieda et al. 2005; Calpe-Berdiel et al. 2005; Kreeft et al.
2005). However, the main drawback of this approach is the
lack of information on biological variability of individual
samples. This limitation, also observed in other areas (Peng
et al. 2003), may be particularly important in the nutrition
field in order to distinguish dietary responders and non-respon-
ders. Therefore, the experimenter should be aware of this
caveat before deciding to pool samples.
The eleven genes whose expression was strongly modified
– Chym, Ela2, Fabp5, Gck, Lepr, Mt2, Nnmt, Orm2, Pnlip,
Saa2, Try4 – were tested for their suitability as markers of
the consumption of the unsaponifiable fraction. Their depen-
dency on genetic background in apoE-deficient mice was
also analysed. Seven of these genes – Chym, Ela2, Fabp5,
Gck, Mt2, Nnmt and Try4 – were representative markers of
the presence of the unsaponifiable fraction of olive oil in the
diet, independent of the genetic background. Three of these
genes – Chym, Ela2 and Try4 – are involved in proteolysis
and showed reduced expression in the UEOO animals. Gck,
an enzyme involved in glucose metabolism and also repressed
in animals receiving high-fat diets, showed similar behaviour
(Dutta et al. 2003). The opposite (up-regulation) was observed
for the expressions of Fabp5, Mt2 and Nnmt. Fabp5 (mal1) is
considered to be an epidermal protein although it is also
expressed in adipocytes (Maeda et al. 2003) and the liver
(see GenBank accession AK167389 for a clone isolated
from a liver cDNA library, and the present data). The exact
role of this protein is not yet completely known, although it
has been proposed to bind leukotriene A4 (Zimmer et al.
2004) and to play a role in systemic insulin sensitivity
(Maeda et al. 2003). The change in its expression induced
by the UEOO diet was particularly dramatic in the C57BL/
6J animals. Mt2 is thought to be associated with obesity
since knock-out mice lacking this gene develop this problem
(Miura & Koizumi, 2005). In both studied substrates, the
expression of this gene was up-regulated (Fig. 4). Nnmt has
been recently associated with plasma homocysteine levels
(Souto et al. 2005). Its genetic background-dependent
response might explain the variation in homocysteine levels
in different strains of mice. Taken as a whole, the present
results suggest that the unsaponifiable components of olive
oil play an important role in controlling the expression of
genes with roles in obesity, insulin sensitivity and cardiovas-
cular risk factors, and that it deserves further attention.
The expression levels of Lepr, Orm2 and Saa2 act as mar-
kers of the presence of the unsaponifiable fraction of olive oil
in the diet, but in a genetic background-dependent fashion. No
increase in plasma serum amyloid A was seen, but circulating
levels of orosomucoid appeared to be elevated in mice with
the hybrid genetic background (C57BL/6J £ OLA129). The
induction of orosomucoids has to date been attributed to
acute phase reactions (Hochepied et al. 2003). In this
regard, the absence of any hepatic steatosis or inflammation
plus a lack of change in serum amyloid A after the adminis-
tration of the unsaponifiable fraction suggests that increased
orosomucoid plasma levels are a unique response elicited by
these compounds via the induction of Orm2 expression.
Recent studies have found that subjects with increased
plasma concentrations of orosomucoid have higher levels of
vitamin A (Thurnham et al. 2003). In addition, in transgenic
mice overexpressing srebp1 and srebp2, transcriptional factors
involved in lipid metabolism, increased expression of this
gene has also been described (Horton et al. 2003) although
at a lower intensity than in mice consuming the UEOO diet.
Together, the data suggest an unknown role for orosomucoid
that might vary depending on the genetic background.
The absence of hepatic steatosis and inflammation after the
administration of either diet is an interesting finding that con-
firms previous data showing hepatic TAG (in other experimen-
tal models) to be reduced when olive oil is consumed (Deng
et al. 2004). This effect is lost, however, when a higher per-
centage olive oil intake is provided or when the intake is
accompanied by cholesterol (Acı´n et al. 2005). Overall, the
results indicate that in dyslipidaemic apoE-deficient mice,
olive oil provides protection against hepatic steatosis until a
certain fat intake is reached. This would be especially true
in low-cholesterol diets such as with the traditional Mediterra-
nean diet.
In conclusion, this nutrigenomic approach clearly illustrates
the important effects of the unsaponifiable fraction of olive oil.
The present results suggest that it is no longer appropriate to
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speak of MUFA-enriched oils (avocado, oleic acid-enriched
safflower, oleic acid-enriched sunflower, olive and peanut
oils) as though all had the same effects. Future studies
should be aware of this to avoid confusion – both to research-
ers and consumers. The present approach also shows new
connections between nutrition and gene expression. A gene
product with unknown biological function, orosomucoid,
was up-regulated to an extent depending on the genetic back-
ground of the mice. Fabp5 and Mt2 were strongly up-regu-
lated while the expression of several proteases was repressed
by the UEOO diet. These modifications in expression could
be used as markers of the intake of the unsaponifiable fraction
of olive oil. The present results also show the usefulness of
Affymetrix chip technology for characterizing gene expression
levels in response to nutritional components in intact animal
systems.
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